TreeWAS – Variant ID: rs1601875

Hospitalization Episode Statistics (HES)

Self-Reported Statistics (SRS)

Hierarchical visualisation How to interpret this figure?

Click here to show this figure without filtering.

Click on a node to zoom (except terminal nodes).

Download this figure in format

Results table

Term	Risk posterior probability	No effect posterior probability	Protective posterior probability
Z35.2 Supervision of pregnancy with other poor reproductive or obstetric history	0.000	0.918	0.082
Z35 Supervision of high-risk pregnancy	0.000	0.919	0.081
Z35.1 Supervision of pregnancy with history of abortive outcome	0.000	0.922	0.078
Z35.8 Supervision of other high-risk pregnancies	0.000	0.931	0.069
Z35.4 Supervision of pregnancy with grand multiparity	0.000	0.931	0.068
Z35.5 Supervision of elderly primigravida	0.000	0.934	0.066
Z35.9 Supervision of high-risk pregnancy, unspecified	0.000	0.939	0.061
Z35.7 Supervision of high-risk pregnancy due to social problems	0.000	0.942	0.058
Z35.6 Supervision of very young primigravida	0.000	0.942	0.058
Z35.3 Supervision of pregnancy with history of insufficient antenatal care	0.000	0.942	0.058
Z35.0 Supervision of pregnancy with history of infertility	0.000	0.951	0.049
D51.0 Vitamin B12 deficiency anaemia due to intrinsic factor deficiency	0.021	0.979	0.000
K10.8 Other specified diseases of jaws	0.016	0.984	0.000
Z36 Antenatal screening	0.000	0.985	0.015
Z30-Z39 Persons encountering health services in circumstances related to reproduction	0.000	0.985	0.015
Z36.9 Antenatal screening, unspecified	0.000	0.986	0.014
Z33 Pregnant state, incidental	0.000	0.986	0.014
Z36.1 Antenatal screening for raised alphafetoprotein level	0.000	0.986	0.014
Z36.0 Antenatal screening for chromosomal anomalies	0.000	0.987	0.013
Z39 Postpartum care and examination	0.000	0.987	0.013
Z36.2 Other antenatal screening based on amniocentesis	0.000	0.988	0.012
Z36.4 Antenatal screening for foetal growth retardation using ultrasound and other physical methods	0.000	0.988	0.012
Z38 Liveborn infants according to place of birth	0.000	0.988	0.011
Z36.5 Antenatal screening for isoimmunisation	0.000	0.989	0.011
D51 Vitamin B12 deficiency anaemia	0.011	0.989	0.000
Z39.1 Care and examination of lactating mother	0.000	0.989	0.011
Z36.3 Antenatal screening for malformations using ultrasound and other physical methods	0.000	0.990	0.010
Z39.2 Routine postpartum follow-up	0.000	0.990	0.010
Z36.8 Other antenatal screening	0.000	0.991	0.009
Z38.0 Singleton, born in hospital	0.000	0.991	0.009
D51.9 Vitamin B12 deficiency anaemia, unspecified	0.009	0.991	0.000
Z39.0 Care and examination immediately after delivery	0.000	0.991	0.009
Z38.8 Other multiple, unspecified as to place of birth	0.000	0.991	0.008
Z38.7 Other multiple, born outside hospital	0.000	0.991	0.008
Z38.6 Other multiple, born in hospital	0.000	0.991	0.008
Z38.5 Twin, unspecified as to place of birth	0.000	0.991	0.008
Z38.4 Twin, born outside hospital	0.000	0.991	0.008
Z38.3 Twin, born in hospital	0.000	0.991	0.008
Z38.2 Singleton, unspecified as to place of birth	0.000	0.991	0.008
Z38.1 Singleton, born outside hospital	0.000	0.991	0.008
D51.8 Other vitamin B12 deficiency anaemias	0.008	0.992	0.000
D51.2 Transcobalamin II deficiency	0.008	0.992	0.000
D51.1 Vitamin B12 deficiency anaemia due to selective vitamin B12 malabsorption with proteinuria	0.008	0.992	0.000
D51.3 Other dietary vitamin B12 deficiency anaemia	0.008	0.992	0.000
K10 Other diseases of jaws	0.007	0.993	0.000
Z34 Supervision of normal pregnancy	0.000	0.993	0.007
Z32 Pregnancy examination and test	0.000	0.993	0.007
T50 Poisoning by diuretics and other and unspecified drugs, medicaments and biological substances	0.007	0.993	0.000
T50.9 Other and unspecified drugs, medicaments and biological substances	0.006	0.994	0.000
K10.0 Developmental disorders of jaws	0.006	0.994	0.000
K10.3 Alveolitis of jaws	0.006	0.994	0.000
T50.6 Antidotes and chelating agents, not elsewhere classified	0.006	0.994	0.000
I51.9 Heart disease, unspecified	0.006	0.994	0.000
K10.2 Inflammatory conditions of jaws	0.006	0.994	0.000
T50.2 Carbonic-anhydrase inhibitors, benzothiadiazides and other diuretics	0.005	0.994	0.000
B37.3 Candidiasis of vulva and vagina	0.005	0.995	0.000
Z34.9 Supervision of normal pregnancy, unspecified	0.000	0.995	0.005
K10.1 Giant cell granuloma, central	0.005	0.995	0.000
Q63.0 Accessory kidney	0.000	0.995	0.005
Q66.8 Other congenital deformities of feet	0.005	0.995	0.000
T45.5 Anticoagulants	0.005	0.995	0.000
T42.4 Benzodiazepines	0.005	0.995	0.000
T50.8 Diagnostic agents	0.005	0.995	0.000
T50.4 Drugs affecting uric acid metabolism	0.005	0.995	0.000
T50.1 Loop [high-ceiling] diuretics	0.005	0.995	0.000
Z32.9 Pregnancy confirmed (erroneous code. See Z321)	0.000	0.995	0.005
T45 Poisoning by primarily systemic and haematological agents, not elsewhere classified	0.005	0.995	0.000
T36-T50 Poisoning by drugs, medicaments and biological substances	0.005	0.995	0.000
T47 Poisoning by agents primarily affecting gastro-intestinal system	0.005	0.995	0.000
T47.1 Other antacids and anti-gastric-secretion drugs	0.005	0.995	0.000
T42 Poisoning by antiepileptic, sedative-hypnotic and anti-Parkinsonism drugs	0.005	0.995	0.000
T50.7 Analeptics and opioid receptor antagonists	0.005	0.995	0.000
T50.5 Appetite depressants	0.005	0.995	0.000
T50.3 Electrolytic, caloric and water-balance agents	0.005	0.995	0.000
T50.0 Mineralocorticoids and their antagonists	0.005	0.995	0.000
T39.1 4-Aminophenol derivatives	0.005	0.995	0.000
K10.9 Disease of jaws, unspecified	0.005	0.995	0.000
Z31 Procreative management	0.000	0.995	0.005
M06.92 Rheumatoid arthritis, unspecified (Upper arm)	0.000	0.995	0.005
N77.1 Vaginitis, vulvitis and vulvovaginitis in infectious and parasitic diseases classified elsewhere	0.005	0.995	0.000
T39 Poisoning by nonopioid analgesics, antipyretics and antirheumatics	0.005	0.995	0.000
T42.1 Iminostilbenes	0.005	0.995	0.000
Z00.0 General medical examination	0.000	0.995	0.005
T45.0 Antiallergic and antiemetic drugs	0.004	0.996	0.000
Q66 Congenital deformities of feet	0.004	0.996	0.000
T47.0 Histamine H(2)-receptor antagonists	0.004	0.996	0.000
S52.00 Fracture of upper end of ulna (closed)	0.000	0.996	0.004
T48 Poisoning by agents primarily acting on smooth and skeletal muscles and the respiratory system	0.004	0.996	0.000
J44.1 Chronic obstructive pulmonary disease with acute exacerbation, unspecified	0.004	0.996	0.000
M06.91 Rheumatoid arthritis, unspecified (Shoulder region)	0.000	0.996	0.004
M06.9 Rheumatoid arthritis, unspecified	0.000	0.996	0.004
T45.2 Vitamins, not elsewhere classified	0.004	0.996	0.000
M06.95 Rheumatoid arthritis, unspecified (Pelvic region and thigh)	0.000	0.996	0.004
Z34.0 Supervision of normal first pregnancy	0.000	0.996	0.004
M05.99 Seropositive rheumatoid arthritis, unspecified (Site unspecified)	0.000	0.996	0.004
H53.1 Subjective visual disturbances	0.004	0.996	0.000
R30.0 Dysuria	0.004	0.996	0.000
T42.8 Anti-Parkinsonism drugs and other central muscle-tone depressants	0.004	0.996	0.000
T45.9 Primarily systemic and haematological agent, unspecified	0.004	0.996	0.000
T45.8 Other primarily systemic and haematological agents	0.004	0.996	0.000
T45.7 Anticoagulant antagonists, vitamin K and other coagulants	0.004	0.996	0.000
T45.6 Fibrinolysis-affecting drugs	0.004	0.996	0.000
T45.4 Iron and its compounds	0.004	0.996	0.000
T45.3 Enzymes, not elsewhere classified	0.004	0.996	0.000
Z32.0 Pregnancy, not (yet) confirmed	0.000	0.996	0.004
T37 Poisoning by other systemic anti-infectives and antiparasitics	0.004	0.996	0.000
T47.4 Other laxatives	0.004	0.996	0.000
T41 Poisoning by anaesthetics and therapeutic gases	0.004	0.996	0.000
T36 Poisoning by systemic antibiotics	0.004	0.996	0.000
M06.96 Rheumatoid arthritis, unspecified (Lower leg)	0.000	0.996	0.004
Q66.9 Congenital deformity of feet, unspecified	0.004	0.996	0.000
T47.9 Agent primarily affecting the gastro-intestinal system, unspecified	0.004	0.996	0.000
T47.8 Other agents primarily affecting the gastro-intestinal system	0.004	0.996	0.000
T47.7 Emetics	0.004	0.996	0.000
T47.6 Antidiarrhoeal drugs	0.004	0.996	0.000
T47.5 Digestants	0.004	0.996	0.000
T47.3 Saline and osmotic laxatives	0.004	0.996	0.000
Q66.0 Talipes equinovarus	0.004	0.996	0.000
Z31.3 Other assisted fertilisation methods	0.000	0.996	0.004
T49 Poisoning by topical agents primarily affecting skin and mucous membrane and by ophthalmological, otorhinolarygological and dental drugs	0.004	0.996	0.000
T42.5 Mixed antiepileptics, not elsewhere classified	0.004	0.996	0.000
T42.3 Barbiturates	0.004	0.996	0.000
T42.2 Succinimides and oxazolidinediones	0.004	0.996	0.000
Z57.2 Occupational exposure to dust	0.004	0.996	0.000
T47.2 Stimulant laxatives	0.004	0.996	0.000
Q66.6 Other congenital valgus deformities of feet	0.004	0.996	0.000
Z57.3 Occupational exposure to other air contaminants	0.004	0.996	0.000
T39.8 Other nonopioid analgesics and antipyretics, not elsewhere classified	0.004	0.996	0.000
Z31.4 Procreative investigation and testing	0.000	0.996	0.004
Z31.5 Genetic counselling	0.000	0.996	0.003
Z31.1 Artifical insemination	0.000	0.996	0.003
Z57 Occupational exposure to risk-factors	0.004	0.996	0.000
S01.0 Open wound of scalp	0.000	0.996	0.004
T39.4 Antirheumatics, not elsewhere classified	0.004	0.996	0.000
T39.2 Pyrazolone derivatives	0.004	0.996	0.000
T82.5 Mechanical complication of other cardiac and vascular devices and implants	0.000	0.996	0.004
Z00.4 General psychiatric examination, not elsewhere classified	0.000	0.996	0.004
Q66.7 Pes cavus	0.004	0.996	0.000
T40.2 Other opioids	0.004	0.996	0.000
T44 Poisoning by drugs primarily affecting the autonomic nervous system	0.004	0.996	0.000
K65.9 Peritonitis, unspecified	0.004	0.996	0.000
T40 Poisoning by narcotics and psychodysleptics [hallucinogens]	0.003	0.996	0.000
M05.9 Seropositive rheumatoid arthritis, unspecified	0.000	0.996	0.004
T48.5 Anti-common-cold drugs	0.003	0.996	0.000
T46 Poisoning by agents primarily affecting the cardiovascular system	0.003	0.996	0.000
T39.3 Other nonsteroidal anti-inflammatory drugs [NSAID]	0.003	0.997	0.000
A41.5 Septicaemia due to other Gram-negative organisms	0.003	0.997	0.000
F43.9 Reaction to severe stress, unspecified	0.003	0.997	0.000
T42.0 Hydantoin derivatives	0.003	0.997	0.000
T48.6 Antiasthmatics, not elsewhere classified	0.003	0.997	0.000
F43 Reaction to severe stress, and adjustment disorders	0.003	0.997	0.000
Q66.5 Congenital pes planus	0.003	0.997	0.000
Q66.4 Talipes calcaneovalgus	0.003	0.997	0.000
Q66.1 Talipes calcaneovarus	0.003	0.997	0.000
T36.4 Tetracyclines	0.003	0.997	0.000
T42.6 Other antiepileptic and sedative-hypnotic drugs	0.003	0.997	0.000
M06.90 Rheumatoid arthritis, unspecified (Multiple sites)	0.000	0.997	0.003
S52.01 Fracture of upper end of ulna (open)	0.000	0.997	0.003
A49.0 Staphylococcal infection, unspecified	0.003	0.997	0.000
Z30 Contraceptive management	0.000	0.997	0.003
Z30.3 Menstrual extraction	0.000	0.997	0.003
T48.7 Other and unspecified agents primarily acting on the respiratory system	0.003	0.997	0.000
T48.4 Expectorants	0.003	0.997	0.000
T48.3 Antitussives	0.003	0.997	0.000
T48.2 Other and unspecified agents primarily acting on muscles	0.003	0.997	0.000
T48.1 Skeletal muscle relaxants [neuromuscular blocking agents]	0.003	0.997	0.000
T48.0 Oxytocic drugs	0.003	0.997	0.000
T45.1 Antineoplastic and immunosuppressive drugs	0.003	0.997	0.000
M05.92 Seropositive rheumatoid arthritis, unspecified (Upper arm)	0.000	0.997	0.003
Q66.3 Other congenital varus deformities of feet	0.003	0.997	0.000
Z31.6 General counselling and advice on procreation	0.000	0.997	0.003
Z32.1 Pregnancy confirmed	0.000	0.997	0.003
M94.26 Chondromalacia (Lower leg)	0.000	0.997	0.003
T39.9 Nonopioid analgesic, antipyretic and antirheumatic, unspecified	0.003	0.997	0.000
Z30.0 General counselling and advice on contraception	0.000	0.997	0.003
M06.94 Rheumatoid arthritis, unspecified (Hand)	0.000	0.997	0.003
F43.0 Acute stress reaction	0.003	0.997	0.000
T37.2 Antimalarials and drugs acting on other blood protozoa	0.003	0.997	0.000
Z00 General examination and investigation of persons without complaint or reported diagnosis	0.000	0.997	0.003
S52.0 Fracture of upper end of ulna	0.000	0.997	0.003
T91.8 Sequelae of other specified injuries of neck and trunk	0.000	0.997	0.003
F43.2 Adjustment disorders	0.003	0.997	0.000
N39.8 Other specified disorders of urinary system	0.003	0.997	0.000
T37.9 Systemic anti-infective and antiparasitic, unspecified	0.003	0.997	0.000
T37.5 Antiviral drugs	0.003	0.997	0.000
T37.4 Anthelminthics	0.003	0.997	0.000
T37.3 Other antiprotozoal drugs	0.003	0.997	0.000
T37.1 Antimycobacterial drugs	0.003	0.997	0.000
T37.0 Sulphonamides	0.003	0.997	0.000
T39.0 Salicylates	0.003	0.997	0.000
Z31.9 Procreative management, unspecified	0.000	0.997	0.003
T36.9 Systemic antibiotic, unspecified	0.003	0.997	0.000
T36.8 Other systemic antibiotics	0.003	0.997	0.000
T36.7 Antifungal antibiotics, systemically used	0.003	0.997	0.000
T36.6 Rifamycins	0.003	0.997	0.000
T36.5 Aminoglycosides	0.003	0.997	0.000
T36.2 Chloramphenicol group	0.003	0.997	0.000
T36.1 Cefalosporins and other Beta-lactam antibiotics	0.003	0.997	0.000
T41.5 Therapeutic gases	0.003	0.997	0.000
T41.4 Anaesthetic, unspecified	0.003	0.997	0.000
T41.3 Local anaesthetics	0.003	0.997	0.000
T41.2 Other and unspecified general anaesthetics	0.003	0.997	0.000
T41.1 Intravenous anaesthetics	0.003	0.997	0.000
T41.0 Inhaled anaesthetics	0.003	0.997	0.000
M05.90 Seropositive rheumatoid arthritis, unspecified (Multiple sites)	0.000	0.997	0.003
Q66.2 Metatarsus varus	0.003	0.997	0.000
T37.8 Other specified systemic anti-infectives and antiparasitics	0.003	0.997	0.000
Z31.8 Other procreative management	0.000	0.997	0.003
Z57.8 Occupational exposure to other risk-factors	0.003	0.997	0.000
M06.93 Rheumatoid arthritis, unspecified (Forearm)	0.000	0.997	0.003
F43.1 Posttraumatic stress disorder	0.003	0.997	0.000
T49.9 Topical agent, unspecified	0.003	0.997	0.000
T49.8 Other topical agents	0.003	0.997	0.000
T49.7 Dental drugs, topically applied	0.003	0.997	0.000
T49.6 Otorhinolaryngological drugs and preparations	0.003	0.997	0.000
T49.5 Ophthalmological drugs and preparations	0.003	0.997	0.000
T49.4 Keratolytics, keratoplastics and other hair treatment drugs and preparations	0.003	0.997	0.000
T49.3 Emollients, demulcents and protectants	0.003	0.997	0.000
T49.2 Local astringents and local detergents	0.003	0.997	0.000
T49.1 Antipruritics	0.003	0.997	0.000
M05.95 Seropositive rheumatoid arthritis, unspecified (Pelvic region and thigh)	0.000	0.997	0.003
M06.98 Rheumatoid arthritis, unspecified (Other)	0.000	0.997	0.003
T36.3 Macrolides	0.003	0.997	0.000
M05.97 Seropositive rheumatoid arthritis, unspecified (Ankle and foot)	0.000	0.997	0.003
T46.0 Cardiac-stimulant glycosides and drugs of similar action	0.003	0.997	0.000
T49.0 Local antifungal, anti-infective and anti-inflammatory drugs, not elsewhere classified	0.003	0.997	0.000
Z31.0 Tuboplasty or vasoplasty after previous sterilisation	0.000	0.997	0.003
Z59 Problems related to housing and economic circumstances	0.003	0.997	0.000
B96.5 Pseudomonas (aeruginosa)(mallei)(pseudomallei) as the cause of diseases classified to other chapters	0.003	0.997	0.000
T42.7 Antiepileptic and sedative-hypnotic drugs, unspecified	0.003	0.997	0.000
T46.6 Antihyperlipidaemic and antiarteriosclerotic drugs	0.003	0.997	0.000
H53.2 Diplopia	0.000	0.997	0.003
Z04.9 Examination and observation for unspecified reason	0.000	0.997	0.003
Z57.9 Occupational exposure to unspecified risk-factor	0.003	0.997	0.000
Z57.7 Occupational exposure to vibration	0.003	0.997	0.000
Z57.6 Occupational exposure to extreme temperature	0.003	0.997	0.000
Z57.4 Occupational exposure to toxic agents in agriculture	0.003	0.997	0.000
Z57.1 Occupational exposure to radiation	0.003	0.997	0.000
Z57.0 Occupational exposure to noise	0.003	0.997	0.000
M06.09 Seronegative rheumatoid arthritis (Site unspecified)	0.000	0.997	0.003
T36.0 Penicillins	0.003	0.997	0.000
Z59.0 Homelessness	0.003	0.997	0.000
T38 Poisoning by hormones and their synthetic substitutes and antagonists, not elsewhere classified	0.003	0.997	0.000
T46.4 Angiotensin-converting-enzyme inhibitors	0.003	0.997	0.000
R80 Isolated proteinuria	0.000	0.997	0.003
T44.8 Centrally acting and afrenergic-neuron-blocking agents, not elsewhere classified	0.003	0.997	0.000
T44.6 Alpha-Adrenoreceeptor antagonists, not elsewhere classified	0.003	0.997	0.000
T44.5 Predominantly Beta-adrenoreceptor agonists, not elsewhere classified	0.003	0.997	0.000
T44.4 Predominantly Alpha-adrenoreceptor agonists, not elsewhere classified	0.003	0.997	0.000
T44.2 Ganglionic blocking drugs, not elsewhere classified	0.003	0.997	0.000
T44.1 Other parasympathomimetics [cholinergics]	0.003	0.997	0.000
T44.0 Anticholinesterase agents	0.003	0.997	0.000
Z37 Outcome of delivery	0.000	0.997	0.003
D50-D53 Nutritional anaemias	0.003	0.997	0.000
T40.9 Other and unspecified psychodysleptics [hallucinogens]	0.003	0.997	0.000
T40.8 Lysergide [LSD]	0.003	0.997	0.000
T40.7 Cannabis (derivatives)	0.003	0.997	0.000
T40.0 Opium	0.003	0.997	0.000
T44.7 Beta-Adrenoreceeptor antagonists, not elsewhere classified	0.003	0.997	0.000
Z00.8 Other general examinations	0.000	0.997	0.003
M05.98 Seropositive rheumatoid arthritis, unspecified (Other)	0.000	0.997	0.003
T46.9 Other and unspecified agents primarily affecting the cardiovascular system	0.003	0.997	0.000
T46.8 Antivaricose drugs, including sclerosing agents	0.003	0.997	0.000
T46.7 Peripheral vasodilators	0.003	0.997	0.000
M05.91 Seropositive rheumatoid arthritis, unspecified (Shoulder region)	0.000	0.997	0.003
F43.8 Other reactions to severe stress	0.003	0.997	0.000
M06.0 Seronegative rheumatoid arthritis	0.000	0.997	0.003
T40.3 Methadone	0.003	0.997	0.000
Z30.8 Other contraceptive management	0.000	0.997	0.003
A39.0 Meningococcal meningitis	0.003	0.997	0.000
D53.9 Nutritional anaemia, unspecified	0.003	0.997	0.000
T40.1 Heroin	0.003	0.997	0.000
Z63.8 Other specified problems related to primary support group	0.003	0.997	0.000
M06 Other rheumatoid arthritis	0.000	0.997	0.003
A39 Meningococcal infection	0.003	0.997	0.000
D53 Other nutritional anaemias	0.003	0.997	0.000
Z55-Z65 Persons with potential health hazards related to socioeconomic and psychosocial circumstances	0.003	0.997	0.000
Z34.8 Supervision of other normal pregnancy	0.000	0.997	0.003
Z57.5 Occupational exposure to toxic agents in other industries	0.003	0.997	0.000
F44 Dissociative [conversion] disorders	0.003	0.997	0.000
Z00.5 Examination of potential donor of organ and tissue	0.000	0.997	0.003
Z59.1 Inadequate housing	0.003	0.997	0.000
M18.0 Primary arthrosis of first carpometacarpal joints, bilateral	0.000	0.997	0.003
M05.94 Seropositive rheumatoid arthritis, unspecified (Hand)	0.000	0.997	0.003
T44.9 Other and unspecified drugs primarily affecting the nervous system	0.002	0.997	0.000
Z59.9 Problem relating to housing and economic circumstances, unspecified	0.003	0.997	0.000
M05.96 Seropositive rheumatoid arthritis, unspecified (Lower leg)	0.000	0.997	0.002
M06.00 Seronegative rheumatoid arthritis (Multiple sites)	0.000	0.997	0.003
C80.0 Malignant neoplasm, primary site unknown, so stated	0.003	0.997	0.000
T46.2 Other antidysrhythmic drugs, not elsewhere classified	0.002	0.997	0.000
Z61.4 Problems related to alleged sexual abuse of child by person within primary support group	0.003	0.997	0.000
Z61 Problems related to negative life events in childhood	0.003	0.997	0.000
T44.3 Other parasympatholytics [anticholinergics and antimuscarines] and spasmolytics, not elsewhere classified	0.002	0.997	0.000
Z00.3 Examination for adolescent development state	0.000	0.997	0.002
Z00.2 Examination for period of rapid growth in childhood	0.000	0.997	0.002
Z00.1 Routine child health examination	0.000	0.997	0.002
Z31.2 In vitro fertilisation	0.000	0.997	0.002
M05.93 Seropositive rheumatoid arthritis, unspecified (Forearm)	0.000	0.997	0.002
M06.97 Rheumatoid arthritis, unspecified (Ankle and foot)	0.000	0.997	0.003
F44.0 Dissociative amnesia	0.003	0.997	0.000
I97.1 Other functional disturbances following cardiac surgery	0.000	0.997	0.003
Z59.2 Discord with neighbours, lodgers and landlord	0.002	0.997	0.000
A41 Other septicaemia	0.003	0.997	0.000
R30 Pain associated with micturition	0.003	0.997	0.000
A41.1 Septicaemia due to other specified staphylococcus	0.003	0.997	0.000
F44.4 Dissociative motor disorders	0.002	0.997	0.000
T40.5 Cocaine	0.002	0.997	0.000
T46.5 Other antihypertensive drugs, not elsewhere classified	0.002	0.997	0.000
A30-A49 Other bacterial diseases	0.003	0.997	0.000
G93.1 Anoxic brain damage, not elsewhere classified	0.002	0.997	0.000
A39.4 Meningococcaemia, unspecified	0.002	0.997	0.000
R30.9 Painful micturition, unspecified	0.002	0.997	0.000
F44.5 Dissociative convulsions	0.002	0.998	0.000
H34.8 Other retinal vascular occlusions	0.002	0.998	0.000
Z30.4 Surveillance of contraceptive drugs	0.000	0.998	0.002
F44.9 Dissociative [conversion] disorder, unspecified	0.002	0.998	0.000
T46.3 Coronary vasodilators, not elsewhere classified	0.002	0.998	0.000
Z30.9 Contraceptive management, unspecified	0.000	0.998	0.002
A46 Erysipelas	0.002	0.998	0.000
T38.1 Thyroid hormones and substitutes	0.002	0.998	0.000
Z59.7 Insufficient social insurance and welfare support	0.002	0.998	0.000
Z59.6 Low income	0.002	0.998	0.000
Z59.5 Extreme poverty	0.002	0.998	0.000
Z59.4 Lack of adequate food	0.002	0.998	0.000
Z59.3 Problems related to living in residential institution	0.002	0.998	0.000
M53.38 Sacrococcygeal disorders, not elsewhere classified-Sacral/s	0.000	0.998	0.002
G80.8 Other infantile cerebral palsy	0.002	0.998	0.000
A49 Bacterial infection of unspecified site	0.002	0.998	0.000
G80 Infantile cerebral palsy	0.002	0.998	0.000
J40 Bronchitis, not specified as acute or chronic	0.000	0.998	0.002
Z65 Problems related to other psychosocial circumstances	0.002	0.998	0.000
E27.4 Other and unspecified adrenocortical insufficiency	0.002	0.998	0.000
G80.2 Infantile hemiplegia	0.002	0.998	0.000
A49.2 Haemophilus influenzae infection, unspecified	0.002	0.998	0.000
G80.9 Infantile cerebral palsy, unspecified	0.002	0.998	0.000
T20.1 Burn of first degree of head and neck	0.002	0.998	0.000
T38.9 Other and unspecified hormone antagonists	0.002	0.998	0.000
T38.7 Androgens and anabolic congeners	0.002	0.998	0.000
T38.5 Other oestrogens and progestogens	0.002	0.998	0.000
T38.4 Oral contraceptives	0.002	0.998	0.000
T38.2 Antithyroid drugs	0.002	0.998	0.000
T38.0 Glucocorticoids and synthetic analogues	0.002	0.998	0.000
G82.2 Paraplegia, unspecified	0.002	0.998	0.000
Z59.8 Other problems relating to housing and economic circumstances	0.002	0.998	0.000
E04.1 Non-toxic single thyroid nodule	0.002	0.998	0.000
H65.9 Nonsuppurative otitis media, unspecified	0.000	0.998	0.002
F48.0 Neurasthenia	0.002	0.998	0.000
Z37.9 Outcome of delivery unspecified	0.000	0.998	0.002
Z37.7 Other multiple births, all stillborn	0.000	0.998	0.002
Z37.6 Other multiple births, some liveborn	0.000	0.998	0.002
Z37.4 Twins, both stillborn	0.000	0.998	0.002
F23.9 Acute and transient psychotic disorder, unspecified	0.000	0.998	0.002
T40.6 Other and unspecified narcotics	0.002	0.998	0.000
Z61.5 Problems related to alleged sexual abuse of child by person outside primary support group	0.002	0.998	0.000
Z58 Problems related to physical environment	0.002	0.998	0.000
M06.8 Other specified rheumatoid arthritis	0.000	0.998	0.002
T38.6 Antigonadotrophins. antioestrogens, antiandrogens, not elsewhere classified	0.002	0.998	0.000
M06.08 Seronegative rheumatoid arthritis (Other)	0.000	0.998	0.002
M06.05 Seronegative rheumatoid arthritis (Pelvic region and thigh)	0.000	0.998	0.002
M06.03 Seronegative rheumatoid arthritis (Forearm)	0.000	0.998	0.002
M06.2 Rheumatoid bursitis	0.000	0.998	0.002
M06.1 Adult-onset Still's disease	0.000	0.998	0.002
T46.1 Calcium-channel blockers	0.002	0.998	0.000
Z58.8 Other problems related to physical environment	0.002	0.998	0.000
Z63 Other problems related to primary support group, including family circumstances	0.002	0.998	0.000
A39.9 Meningococcal infection, unspecified	0.002	0.998	0.000
A39.8 Other meningococcal infections	0.002	0.998	0.000
A39.5 Meningococcal heart disease	0.002	0.998	0.000
A39.3 Chronic meningococcaemia	0.002	0.998	0.000
A39.2 Acute meningococcaemia	0.002	0.998	0.000
A39.1 Waterhouse-Friderichsen syndrome	0.002	0.998	0.000
D53.8 Other specified nutritional anaemias	0.002	0.998	0.000
D53.2 Scorbutic anaemia	0.002	0.998	0.000
D53.0 Protein deficiency anaemia	0.002	0.998	0.000
F44.8 Other dissociative [conversion] disorders	0.002	0.998	0.000
M06.07 Seronegative rheumatoid arthritis (Ankle and foot)	0.000	0.998	0.002
M06.04 Seronegative rheumatoid arthritis (Hand)	0.000	0.998	0.002
A41.0 Septicaemia due to Staphylococcus aureus	0.002	0.998	0.000
F44.7 Mixed dissociative [conversion] disorders	0.002	0.998	0.000
F44.6 Dissociative anaesthesia and sensory loss	0.002	0.998	0.000
F44.3 Trance and possession disorders	0.002	0.998	0.000
F44.2 Dissociative stupor	0.002	0.998	0.000
F44.1 Dissociative fugue	0.002	0.998	0.000
K22.2 Oesophageal obstruction	0.002	0.998	0.000
T38.8 Other and unspecified hormones and their synthetic substitutes	0.002	0.998	0.000
Z65.8 Other specified problems related to psychosocial circumstances	0.002	0.998	0.000
Z62 Other problems related to upbringing	0.002	0.998	0.000
Z55 Problems related to education and literacy	0.002	0.998	0.000
A41.2 Septicaemia due to unspecified staphylococcus	0.002	0.998	0.000
G80.0 Spastic cerebral palsy	0.002	0.998	0.000
F48 Other neurotic disorders	0.002	0.998	0.000
D53.1 Other megaloblastic anaemias, not elsewhere classified	0.002	0.998	0.000
M06.3 Rheumatoid nodule	0.000	0.998	0.002
M18.9 Arthrosis of first carpometacarpal joint, unspecified	0.000	0.998	0.002
R30.1 Vesical tenesmus	0.002	0.998	0.000
M06.01 Seronegative rheumatoid arthritis (Shoulder region)	0.000	0.998	0.002
M06.30 Rheumatoid nodule (Multiple sites)	0.000	0.998	0.002
D47.1 Chronic myeloproliferative disease	0.002	0.998	0.000
N85.9 Noninflammatory disorder of uterus, unspecified	0.002	0.998	0.000
Z37.1 Single stillbirth	0.000	0.998	0.002
Z61.9 Negative life events in childhood, unspecified	0.002	0.998	0.000
Z61.8 Other negative life events in childhood	0.002	0.998	0.000
Z61.7 Personal frightening experience in childhood	0.002	0.998	0.000
Z61.3 Events resulting in loss of self-esteem in childhood	0.002	0.998	0.000
Z61.2 Altered pattern of family relationships in childhood	0.002	0.998	0.000
Z61.1 Removal from home in childhood	0.002	0.998	0.000
Z61.0 Loss of love relationship in childhood	0.002	0.998	0.000
Z37.5 Other multiple births, all liveborn	0.000	0.998	0.002
A48 Other bacterial diseases, not elsewhere classified	0.002	0.998	0.000
A41.4 Septicaemia due to anaerobes	0.002	0.998	0.000
A41.3 Septicaemia due to Haemophilus influenzae	0.002	0.998	0.000
Z65.9 Problem related to unspecified psychosocial circumstances	0.002	0.998	0.000
A31 Infection due to other mycobacteria	0.002	0.998	0.000
N77 Vulvovaginal ulceration and inflammation in diseases classified elsewhere	0.002	0.998	0.000
T20 Burn and corrosion of head and neck	0.002	0.998	0.000
M06.02 Seronegative rheumatoid arthritis (Upper arm)	0.000	0.998	0.002
M06.80 Other specified rheumatoid arthritis (Multiple sites)	0.000	0.998	0.002
T20.2 Burn of second degree of head and neck	0.002	0.998	0.000
A44 Bartonellosis	0.002	0.998	0.000
A43 Nocardiosis	0.002	0.998	0.000
A42 Actinomycosis	0.002	0.998	0.000
A37 Whooping cough	0.002	0.998	0.000
A36 Diphtheria	0.002	0.998	0.000
A32 Listeriosis	0.002	0.998	0.000
A30 Leprosy [Hansen's disease]	0.002	0.998	0.000
A38 Scarlet fever	0.002	0.998	0.000
A35 Other tetanus	0.002	0.998	0.000
A34 Obstetrical tetanus	0.002	0.998	0.000
A33 Tetanus neonatorum	0.002	0.998	0.000
G82.1 Spastic paraplegia	0.002	0.998	0.000
M06.4 Inflammatory polyarthropathy	0.000	0.998	0.002
Z64 Problems related to certain psychosocial circumstances	0.002	0.998	0.000
G40.2 Localisation-related (focal) (partial) symptomatic epilepsy and epileptic syndromes with complex partial seizures	0.002	0.998	0.000
G80.1 Spastic diplegia	0.002	0.998	0.000
T83.1 Mechanical complication of other urinary devices and implants	0.000	0.998	0.002
M06.06 Seronegative rheumatoid arthritis (Lower leg)	0.000	0.998	0.002
E27.1 Primary adrenocortical insufficiency	0.002	0.998	0.000
F48.9 Neurotic disorder, unspecified	0.002	0.998	0.000
A49.3 Mycoplasma infection, unspecified	0.002	0.998	0.000
M18 Arthrosis of first carpometacarpal joint	0.000	0.998	0.002
G80.4 Ataxic cerebral palsy	0.002	0.998	0.000
G80.3 Dyskinetic cerebral palsy	0.002	0.998	0.000
R26.2 Difficulty in walking, not elsewhere classified	0.002	0.998	0.000
Y42.7 Androgens and anabolic congeners	0.002	0.998	0.000
Z65.5 Exposure to disaster, war and other hostilities	0.002	0.998	0.000
Z65.4 Victim of crime and terrorism	0.002	0.998	0.000
Z65.2 Problems related to release from prison	0.002	0.998	0.000
Z65.1 Imprisonment and other incarceration	0.002	0.998	0.000
Z65.0 Conviction in civil and criminal proceedings without imprisonment	0.002	0.998	0.000
E13.9 Without complications	0.002	0.998	0.000
T40.4 Other synthetic narcotics	0.002	0.998	0.000
Z63.6 Dependent relative needing care at home	0.002	0.998	0.000
Z37.3 Twins, one liveborn and one stillborn	0.000	0.998	0.002
G82 Paraplegia and tetraplegia	0.002	0.998	0.000
F40-F48 Neurotic, stress-related and somatoform disorders	0.002	0.998	0.000
E27.8 Other specified disorders of adrenal gland	0.002	0.998	0.000
M06.34 Rheumatoid nodule (Hand)	0.000	0.998	0.002
M06.40 Inflammatory polyarthropathy (Multiple sites)	0.000	0.998	0.002
T20.3 Burn of third degree of head and neck	0.002	0.998	0.000
M06.88 Other specified rheumatoid arthritis (Other)	0.000	0.998	0.002
M06.87 Other specified rheumatoid arthritis (Ankle and foot)	0.000	0.998	0.002
M06.86 Other specified rheumatoid arthritis (Lower leg)	0.000	0.998	0.002
M06.85 Other specified rheumatoid arthritis (Pelvic region and thigh)	0.000	0.998	0.002
M06.84 Other specified rheumatoid arthritis (Hand)	0.000	0.998	0.002
M06.83 Other specified rheumatoid arthritis (Forearm)	0.000	0.998	0.002
M06.82 Other specified rheumatoid arthritis (Upper arm)	0.000	0.998	0.002
M06.81 Other specified rheumatoid arthritis (Shoulder region)	0.000	0.998	0.002
Z58.9 Problem related to physical environment, unspecified	0.002	0.998	0.000
Z58.6 Inadequate drinking-water supply	0.002	0.998	0.000
Z58.4 Exposure to radiation	0.002	0.998	0.000
Z58.3 Exposure to soil pollution	0.002	0.998	0.000
Z58.2 Exposure to water pollution	0.002	0.998	0.000
Z58.0 Exposure to noise	0.002	0.998	0.000
Z63.0 Problems in relationship with spouse or partner	0.002	0.998	0.000
M94.2 Chondromalacia	0.000	0.998	0.002
Z63.9 Problem related to primary support group, unspecified	0.002	0.998	0.000
Z63.3 Absence of family member	0.002	0.998	0.000
Z63.2 Inadequate family support	0.002	0.998	0.000
Z63.1 Problems in relationship with parents and in-laws	0.002	0.998	0.000
Z65.3 Problems related to other legal circumstances	0.002	0.998	0.000
E27 Other disorders of adrenal gland	0.002	0.998	0.000
Q63 Other congenital malformations of kidney	0.000	0.998	0.002
M06.19 Adult-onset Still's disease (Site unspecified)	0.000	0.998	0.002
M06.18 Adult-onset Still's disease (Other)	0.000	0.998	0.002
M06.17 Adult-onset Still's disease (Ankle and foot)	0.000	0.998	0.002
M06.16 Adult-onset Still's disease (Lower leg)	0.000	0.998	0.002
M06.15 Adult-onset Still's disease (Pelvic region and thigh)	0.000	0.998	0.002
M06.14 Adult-onset Still's disease (Hand)	0.000	0.998	0.002
M06.13 Adult-onset Still's disease (Forearm)	0.000	0.998	0.002
M06.12 Adult-onset Still's disease (Upper arm)	0.000	0.998	0.002
M06.11 Adult-onset Still's disease (Shoulder region)	0.000	0.998	0.002
M06.10 Adult-onset Still's disease (Multiple sites)	0.000	0.998	0.002
M06.29 Rheumatoid bursitis (Site unspecified)	0.000	0.998	0.002
M06.28 Rheumatoid bursitis (Other)	0.000	0.998	0.002
M06.27 Rheumatoid bursitis (Ankle and foot)	0.000	0.998	0.002
M06.26 Rheumatoid bursitis (Lower leg)	0.000	0.998	0.002
M06.25 Rheumatoid bursitis (Pelvic region and thigh)	0.000	0.998	0.002
M06.24 Rheumatoid bursitis (Hand)	0.000	0.998	0.002
M06.23 Rheumatoid bursitis (Forearm)	0.000	0.998	0.002
M06.22 Rheumatoid bursitis (Upper arm)	0.000	0.998	0.002

This table lists the top 500 terms ordered by p(effect).

The full results table can be downloaded from this page.

The TreeWAS Database is the result of research conducted at the Oxford Big Data Institute at the University of Oxford.

This research has been conducted using the UK Biobank Resource (application number 10625). This work uses data provided by patients and collected by the NHS as part of their care and support.

This research has been conducted with the support of the Wellcome Trust (100956/Z/13/Z and 090532/Z/09/Z and 100308/Z/12/Z), the Danish National Research Foundation, Takeda, the Medical Research Council (MC_UU_12010/3), the Oak Foundation (OCAY-15-520), the National Institute for Health Research (NIHR) Oxford Biomedical Research Centre (BRC), the Wellcome Trust/Royal Society (204290/Z/16/Z) and the Li Ka Shing Foundation.

Variant-specific associations